Changes of Hemostatic Molecular Markers After Gynecological Surgery
Kazuhiko Noda,Hideo Wada,Norikazu Yamada,Naomi Noda,Esteban C. Gabazza,Kouzou Kumeda,Toshiharu Okugawa,Kenji Yanoh,Masazumi Ito,Takeshi Nakano,Hiroshi Shiku,Tsutomu Nobori,Hisao Kato,Nagayasu Toyoda
DOI: https://doi.org/10.1177/107602960000600403
2000-10-01
Clinical and Applied Thrombosis/Hemostasis
Abstract:The authors evaluated the hemostatic abnormalities occurring in the postoperative period of eight patients with malignant tumors and compared them with those occurring in the postoperative period of eight patients with benign tumors. Two of the patients with malignant tumor presented pulmonary embolism after operation. Plasma fibrinogen and fibrin degra dation product levels in patients with malignant tumors were already high before operation and further increased signifi cantly after operation. The plasma levels of D-dimer, thrombi n-antithrombin complex, and free-tissue factor pathway inhibi tor were increased in both groups after operation, but they were higher in patients with malignant tumors than in patients with benign tumors. The plasma levels of protein C and antithrom bin were significantly decreased in both groups after operation, but they were significantly lower in patients with malignant tumors than in those with benign tumors. The decreased activ ity of protein C or antithrombin may be not only a risk factor of thrombotic disease, such as pulmonary embolism, but also the cause of thrombosis. In patients with malignant tumors, the operation time was significantly longer than that in patients with benign tumors. This long operative period might cause vascular endothelial cell injury which is reflected by the plasma levels of free-tissue factor pathway inhibitor, antithrombin, and protein C.
peripheral vascular disease,hematology